ALIUD PHARMA GMBH — Tamoxifen Importer Profile
Pharmaceutical Importer · #2 buyer for Tamoxifen · $886.6K import value · 25 shipments · BELGIUM · DGFT Verified
ALIUD PHARMA GMBH is the #2 importer of Tamoxifen from India with $886.6K in import value and 25 verified shipments. ALIUD PHARMA GMBH holds a 8.5% market share in Tamoxifen imports based in BELGIUM. The company sources from 1 verified supplier across 9 formulations shipped to 2 countries.
ALIUD PHARMA GMBH — Tamoxifen Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Tamoxifen to ALIUD PHARMA GMBH?
Verified from 25 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| GRANULES INDIA LIMITED | $886.6K | 25 | 100.0% |
ALIUD PHARMA GMBH sources Tamoxifen from 1 verified Indian supplier based on 25 customs records. The primary supplier is GRANULES INDIA LIMITED accounting for 100.0% of imports.
How Does ALIUD PHARMA GMBH Compare to Nearest Tamoxifen Importers?
Buyers ranked immediately above and below #2 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | AUROBINDO PHARMA USA., INC, | UNITED STATES | $2.5M | 85 | $29.8K |
| 2 | ALIUD PHARMA GMBH ★ | GERMANY | $1.3M | 25 | $50.0K |
| 3 | AUROBINDO PHARMA USA INC | UNITED STATES | $1.2M | 25 | $47.3K |
| 4 | AUROLOGISTICS LLC, (AUROBINDO PHARM | UNITED STATES | $1.1M | 23 | $50.0K |
ALIUD PHARMA GMBH ranks #2 among 377 Tamoxifen importers from India. Average shipment value of $50.0K compared to the market average of $23.5K. The closest competitors by value are AUROBINDO PHARMA USA., INC, and AUROBINDO PHARMA USA INC.
Where Does ALIUD PHARMA GMBH Import Tamoxifen To?
Destination countries from 25 verified shipments
ALIUD PHARMA GMBH imports Tamoxifen to 2 countries. The primary destination is BELGIUM receiving 53.9% of shipments worth $478.2K.
What Tamoxifen Formulations Does ALIUD PHARMA GMBH Import?
| Formulation | Value | Shipments |
|---|---|---|
| TAMOXIFEN AL 20 10X10 S ST ADA AL | $404.8K | 11 |
| Tamoxifen AL 20,10x10's-STADA/AL | $100.0K | 2 |
| TAMOXIFEN AL20,10X10'S STADA/AL-BATCH NO:N251A0006A, N251A0007A & N251A0008A | $100.0K | 2 |
| TAMOXIFEN AL20,10X10'S STADA/AL BATCH NO:N251A0004A & N251A0005A | $88.2K | 2 |
| TAMOXIFEN AL 20 3X10 S ST ADA AL DE | $73.4K | 3 |
| TAMOXIFEN AL 20 10X10S 2879800 NOS STADA AL | $50.0K | 1 |
| TAMOXIFEN AL30,10X10'S STADA/AL-BATCH NO:N251A0001A, N251A0002A&N251A0003A | $31.6K | 2 |
| Tamoxifen AL 20, 3x10s-STADA/AL DE | $21.3K | 1 |
| TAMOXIFEN AL30, 10X10S-STADA/AL DE(2396 | $17.4K | 1 |
ALIUD PHARMA GMBH imports 9 distinct Tamoxifen formulations from India. The top formulation is TAMOXIFEN AL 20 10X10 S ST ADA AL with 11 shipments worth $404.8K.
Who Are the Top Buyers of Tamoxifen from India and How Much Does ALIUD PHARMA GMBH Import?
India exported $8.9M worth of Tamoxifen through 3,139 shipments from 220 suppliers to 104 countries, serving 377 buyers globally. ALIUD PHARMA GMBH imports $886.6K of this total, accounting for 8.5% of India's Tamoxifen exports with 25 shipments from BELGIUM. This is verified from 25 customs shipment records covering 9 distinct formulations.
What Is the Average Order Value for ALIUD PHARMA GMBH's Tamoxifen Imports?
ALIUD PHARMA GMBH's average Tamoxifen order value is $35.5K per consignment, based on 25 shipments totaling $886.6K. ALIUD PHARMA GMBH is based in BELGIUM and ranks #2 among all Tamoxifen importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Tamoxifen to ALIUD PHARMA GMBH?
ALIUD PHARMA GMBH sources Tamoxifen from 1 verified Indian supplier: GRANULES INDIA LIMITED ($886.6K, 100.0%). This is based on 25 customs records.
How Does ALIUD PHARMA GMBH Compare to Other Tamoxifen Importers?
ALIUD PHARMA GMBH ranks #2 among 377 Tamoxifen importers from India with a 8.5% market share. The top 3 importers are AUROBINDO PHARMA USA., INC, ($2.5M), ALIUD PHARMA GMBH ($1.3M), AUROBINDO PHARMA USA INC ($1.2M). ALIUD PHARMA GMBH processed 25 shipments from BELGIUM.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Tamoxifen — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Tamoxifen shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: ALIUD PHARMA GMBH matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as ALIUD PHARMA GMBH's capped import value divided by total capped export value for Tamoxifen across all Indian exporters.
- 5.Verified Records: This page is backed by 25 individual customs records matching ALIUD PHARMA GMBH importing Tamoxifen, covering 9 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 104+ countries, 377+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Tamoxifen Import Data for ALIUD PHARMA GMBH
Access order-level details, pricing data, supplier connections, and competitive analysis for ALIUD PHARMA GMBH's Tamoxifen imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
ALIUD PHARMA GMBH
Company Profile
Multiple products · $0 total trade · Multiple categories
ALIUD PHARMA GMBH × Tamoxifen
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for ALIUD PHARMA GMBH.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Tamoxifen. For current order-level data, contact TransData Nexus.